Two dose version of Johnson & Johnson vaccine 94% effective against Covid-19, study finds
Two dose version of Johnson & Johnson vaccine 94% effective against Covid-19, study finds
By Maggie Fox | CNN
A two-dose version of Johnson & Johnson’s coronavirus vaccine provides 94% protection against symptomatic infection, the company said Tuesday — making a two-dose regimen of J&J’s Janssen vaccine comparable to a two-dose regimen of Moderna’s or Pfizer’s.
Plus, the company said, adding a booster dose to a single shot of the vaccine raised immunity even more, and should also…
Discover more from USNewsRank
Subscribe to get the latest posts sent to your email.